Amy L. Burroughs - Net Worth and Insider Trading
Amy L. Burroughs Net Worth
The estimated net worth of Amy L. Burroughs is at least $182,947 dollars as of 2024-09-20. Amy L. Burroughs is the Director of DiaMedica Therapeutics Inc and owns about 44,950 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $182,947. Details can be seen in Amy L. Burroughs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy L. Burroughs has not made any transactions after 2021-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Amy L. Burroughs
Amy L. Burroughs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amy L. Burroughs owns 2 companies in total, including DiaMedica Therapeutics Inc (DMAC) , and Tenaya Therapeutics Inc (TNYA) .
Click here to see the complete history of Amy L. Burroughs’s form 4 insider trades.
Insider Ownership Summary of Amy L. Burroughs
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DMAC | DiaMedica Therapeutics Inc | 2021-08-16 | director |
TNYA | Tenaya Therapeutics Inc | 2022-12-05 | director |
Amy L. Burroughs Latest Holdings Summary
Amy L. Burroughs currently owns a total of 1 stock. Amy L. Burroughs owns 44,950 shares of DiaMedica Therapeutics Inc (DMAC) as of August 16, 2021, with a value of $182,947.
Latest Holdings of Amy L. Burroughs
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DMAC | DiaMedica Therapeutics Inc | 2021-08-16 | 44,950 | 4.07 | 182,947 |
Holding Weightings of Amy L. Burroughs
Amy L. Burroughs Form 4 Trading Tracker
According to the SEC Form 4 filings, Amy L. Burroughs has made a total of 1 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 44,950 shares on August 16, 2021, which cost Amy L. Burroughs around $141,592.
Insider Trading History of Amy L. Burroughs
- 1
Amy L. Burroughs Trading Performance
GuruFocus tracks the stock performance after each of Amy L. Burroughs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy L. Burroughs is 23.4%. GuruFocus also compares Amy L. Burroughs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy L. Burroughs within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amy L. Burroughs's insider trading performs compared to the benchmark.
Performance of Amy L. Burroughs
Amy L. Burroughs Ownership Network
Amy L. Burroughs Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Amy L. Burroughs is the director of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include 10 percent owner Jan Stahlberg , 10 percent owner Koch Thomas Von , and CFO and Secretary Scott Kellen .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Amy L. Burroughs made no insider transaction in DiaMedica Therapeutics Inc (DMAC). Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 527,114 shares made by David J. Wambeke , a net purchase of 2,670,588 shares made by Koch Thomas Von , and a net purchase of 1,200,000 shares made by Jan Stahlberg .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 2,400,000 shares, with a net purchase of 2,400,000 shares. During the past 18 months, 0 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 4,536,639 shares were bought by its insiders, resulting in a net purchase of 4,536,639 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Amy L. Burroughs Mailing Address
Above is the net worth, insider trading, and ownership report for Amy L. Burroughs. You might contact Amy L. Burroughs via mailing address: Two Carlson Parkway, Suite 260, Minneapolis Mn 55447.